VINTOR

This brand name is authorized in Nigeria. It is also authorized in Albania, Turkey.

Active ingredients

The drug VINTOR contains one active pharmaceutical ingredient (API):

1	Fingolimod UNII G926EC510T - FINGOLIMOD HYDROCHLORIDE
	Fingolimod is a sphingosine 1-phosphate receptor modulator. Fingolimod is metabolised by sphingosine kinase to the active metabolite fingolimod phosphate. By acting as a functional antagonist of S1P receptors on lymphocytes, fingolimod phosphate blocks the capacity of lymphocytes to egress from lymph nodes, causing a redistribution, rather than depletion, of lymphocytes.
	Read more about Fingolimod

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-0076	Injection	VINTOR 4000 INJECTIONS INJ 4000IU 1pfs4000	VINTOR 4000 INJECTIONS RECOMBINANT HUMAN ERYTHROPIETIN Each Prefilled syringe contains: Erythropoietin Concentrated solution Ph.Eur 4000IU A6-0076 Vaccines & Biologicals Biologics Imported Products 1pfs4000 22/01/2020 Emcure Nigeria Limited, 2-4, Block C, Amuwo Odofin Industrial Scheme, Apapa-Oshodi Express, CFAO motors compound Lagos, Nigeria 8037749701 emcurenigerialtd@gmail.com Gennova Biopharmaceuticals Limited, Blook 1, Plot No P-1 and P-2, ITBT Park, Phase II, MIDC, Hinjwardi, Pune-411057, Maharashtra State, India, India	26/08/2022
A6-0077	Injection	VINTOR 2000 INJECTION INJ 2000 IU 1 pfs x 2000IU	VINTOR 2000 INJECTION RECOMBINNT HUMAN ERYTHROPOETIN Each Prefilled syringe contains: Recombinant human Erythropoetin 2000IU A6-0077 Vaccines & Biologicals Biologics Imported Products 1 pfs x 2000IU 22/01/2020 Emcure Nigeria Limited, 2-4, Block C, Amuwo Odofin Industrial Scheme, Apapa-Oshodi Express, CFAO motors compound Lagos, Nigeria 8037749701 emcurenigerialtd@gmail.com Gennova Biopharmaceuticals Limited, Blook 1, Plot No P-1 and P-2, ITBT Park, Phase II, MIDC, Hinjwardi, Pune-411057, Maharashtra State, India, India	26/08/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AE01	Fingolimod	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AE Sphingosine-1-phosphate (S1P) receptor modulators
Discover more medicines within L04AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	584/410
NG	Registered Drug Product Database	A6-0076, A6-0077
TR	İlaç ve Tıbbi Cihaz Kurumu	8699536150413, 8699536150420